Yuwaraj Kadariya

1.0k citations

26 papers · 727 indexed · h-index 12

Pulmonary and Respiratory Medicine top 10%
- Occupational and environmental lung diseases 16
- Medical Imaging and Pathology Studies 7
- Pleural and Pulmonary Diseases 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
Biotechnology top 10%
Cancer Research
- Carcinogens and Genotoxicity Assessment 4
Immunology and Allergy top 10%
Oncology
Molecular Biology
- Cancer-related gene regulation 7
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3

Co-authors: Joseph R. Testa Craig W. Menges Mitchell Cheung Andres J. Klein–Szanto Kathy Q. Cai Eleonora Sementino Jianming Pei Jacqueline Talarchek
Cited by: Pulmonary and Respiratory Medicine Biotechnology Cancer Research
Journals: PLoS ONE (1 paper)Cancer Research (5 papers)Biochemical Journal (1 paper)
Partner nations: United States Japan Italy

In The Last Decade

Yuwaraj Kadariya

25 papers receiving 721 citations

Peers

Countries citing papers authored by Yuwaraj Kadariya

Since Specialization

Citations

This map shows the geographic impact of Yuwaraj Kadariya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwaraj Kadariya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwaraj Kadariya more than expected).

Fields of papers citing papers by Yuwaraj Kadariya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwaraj Kadariya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwaraj Kadariya. The network helps show where Yuwaraj Kadariya may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuwaraj Kadariya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuwaraj Kadariya Line = papers co-authored together Yuwaraj Kadariya links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spontaneous Mesotheliomas in Germline Bap1 Heterozygous Mice from Different Genetic Backgrounds Cancers ·Yuwaraj Kadariya,Li Zhang,Eleonora Sementino,Eric A. Ross,Joseph R. Testa	2025	0
2	Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1 -mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment Cancer Research Communications ·Yuwaraj Kadariya,Eleonora Sementino,Maggie Ruan,Mitchell Cheung,Parham Hadikhani,Hatice U. Osmanbeyoglu,Andres J. Klein–Szanto,Kathy Q. Cai,Joseph R. Testa	2024	4
3	Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability Cancers ·Yurong Song,Shaneen S. Baxter,Lisheng Dai,Chelsea Sanders,Sandra Burkett,Ryan N. Baugher,Stephanie D. Mellott,Todd B. Young,Heidi E. Lawhorn,Simone Difilippantonio,Baktiar Karim,Yuwaraj Kadariya,Lígia A. Pinto,Joseph R. Testa,Robert H. Shoemaker	2022	1
4	Synthetic Secoisolariciresinol Diglucoside (LGM2605) Prevents Asbestos-Induced Inflammation and Genotoxic Cell Damage in Human Mesothelial Cells International Journal of Molecular Sciences ·Ralph A. Pietrofesa,Shampa Chatterjee,Yuwaraj Kadariya,Joseph R. Testa,Steven Μ. Albelda,Melpo Christofidou‐Solomidou	2022	5
5	Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models Cancer Research ·Anna-Mariya Kukuyan,Eleonora Sementino,Yuwaraj Kadariya,Craig W. Menges,Mitchell Cheung,Yinfei Tan,Kathy Q. Cai,Michael Slifker,Suraj Peri,Andres J. Klein–Szanto,Frank J. Rauscher,Joseph R. Testa	2019	41
6	Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas Journal of Cellular Physiology ·Eleonora Sementino,Craig W. Menges,Yuwaraj Kadariya,Suraj Peri,Jinfei Xu,Zemin Liu,Richard G. Wilkes,Kathy Q. Cai,Frank J. Rauscher,Andres J. Klein–Szanto,Joseph R. Testa	2018	23
7	Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma Cancer Prevention Research ·Yuwaraj Kadariya,Craig W. Menges,Jacqueline Talarchek,Kathy Q. Cai,Andres J. Klein–Szanto,Ralph A. Pietrofesa,Melpo Christofidou‐Solomidou,Mitchell Cheung,Brooke T. Mossman,Arti Shukla,Joseph R. Testa	2016	59
8	Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations Cancer Research ·Yuwaraj Kadariya,Mitchell Cheung,Jinfei Xu,Jianming Pei,Eleonora Sementino,Craig W. Menges,Kathy Q. Cai,Frank J. Rauscher,Andres J. Klein–Szanto,Joseph R. Testa	2016	79
9	Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction Cancer Letters ·Mitchell Cheung,Yuwaraj Kadariya,Jacqueline Talarchek,Jianming Pei,Jill Ohar,Omar Kayaleh,Joseph R. Testa	2015	33
10	An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation Cancer Genetics ·Mitchell Cheung,Yuwaraj Kadariya,Jianming Pei,Jacqueline Talarchek,Francesco Facciolo,Paolo Visca,Luisella Righi,Ilaria Cozzi,Joseph R. Testa,Valeria Ascoli	2015	10
11	Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice Cancer Biology & Therapy ·Yinfei Tan,Eleonora Sementino,Jianming Pei,Yuwaraj Kadariya,Timothy Ito,Joseph R. Testa	2015	16
12	Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma Cancer Research ·Jinfei Xu,Yuwaraj Kadariya,Mitchell Cheung,Jianming Pei,Jacqueline Talarchek,Eleonora Sementino,Yinfei Tan,Craig W. Menges,Kathy Q. Cai,Samuel Litwin,Hongzhuang Peng,Jayashree Karar,Frank J. Rauscher,Joseph R. Testa	2014	107
13	Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53–miR-34a–c-Met Axis Cancer Research ·Craig W. Menges,Yuwaraj Kadariya,Deborah A. Altomare,Jacqueline Talarchek,Erin Neumann-Domer,Yue Wu,Guang‐Hui Xiao,Irina M. Shapiro,Vihren N. Kolev,Jonathan A. Pachter,Andres J. Klein–Szanto,Joseph R. Testa	2013	47
14	Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice PLoS ONE ·Yuwaraj Kadariya,Baiqing Tang,Liqun Wang,Tahseen Al‐Saleem,Kyoko Hayakawa,Michael Slifker,Warren D. Kruger	2013	9
15	Chemical Genetic Screening for Compounds That Preferentially Inhibit Growth of Methylthioadenosine Phosphorylase (MTAP)–Deficient Saccharomyces cerevisiae SLAS DISCOVERY ·Yuwaraj Kadariya,Baiqing Tang,Cynthia B. Myers,Jami Fukui,Jeffrey R. Peterson,Warren D. Kruger	2010	4
16	Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase ( MTAP ) Die Prematurely of T-Cell Lymphoma Cancer Research ·Yuwaraj Kadariya,Bu Yin,Baiqing Tang,Susan A. Shinton,Eoin P. Quinlivan,Hua Xiang,Andres J. Klein–Szanto,Tahseen Al‐Saleem,Craig H. Bassing,Richard R. Hardy,Warren D. Kruger	2009	43
17	The methionine salvage pathway compound 4-methylthio-2-oxobutanate causes apoptosis independent of down-regulation of ornithine decarboxylase Biochemical Pharmacology ·Baiqing Tang,Yuwaraj Kadariya,Maureen E. Murphy,Warren D. Kruger	2006	19
18	Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y) Biochemical Journal ·Yuwaraj Kadariya,Kaname Nakatani,Junji Nishioka,Takahiko Fujikawa,Warren D. Kruger,Tsutomu Nobori	2005	4
19	Molecular characterization of 5′‐deoxy‐5′‐methylthioadenosine phosphorylase‐deficient mutant clones of murine lymphoma cell line R1.1 Cancer Science ·Yuwaraj Kadariya,Junji Nishioka,Akiko Nakamura,Keiko Kato‐Nakazawa,Tsutomu Nobori	2003	2
20	Deletion of Dinucleotide Repeat (Δ14 Allele) in the Methylthioadenosine Phosphorylase (MTAP) Promoter and the Allelotype of MTAP Promoter in the Japanese Population Japanese Journal of Cancer Research ·Yuwaraj Kadariya,Junji Nishioka,Kaname Nakatani,Kunio Nakashima,Tsutomu Nobori	2002	2

About Yuwaraj Kadariya

Yuwaraj Kadariya is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research, having authored 26 papers that have together received 727 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (16 papers), Cancer-related gene regulation (7 papers), Medical Imaging and Pathology Studies (7 papers), Carcinogens and Genotoxicity Assessment (4 papers), Pleural and Pulmonary Diseases (4 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (374 citations), Biotechnology (87 citations) and Cancer Research (131 citations). Yuwaraj Kadariya has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Joseph R. Testa, Craig W. Menges, Mitchell Cheung, Andres J. Klein–Szanto, Kathy Q. Cai, Eleonora Sementino, Jianming Pei, Jacqueline Talarchek, Frank J. Rauscher and Irina M. Shapiro. Their work appears in journals such as PLoS ONE, Cancer Research and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact